Please use this identifier to cite or link to this item: https://doi.org/10.12688/f1000research.10736.1
Title: Recent advances in acute promyelocytic leukaemia
Authors: Ng, C.-H 
Chng, W.-J 
Keywords: arsenic trioxide
CD135 antigen
retinoic acid
tyrosine kinase receptor
cancer classification
cancer incidence
cancer prognosis
cancer recurrence
cancer regression
cell proliferation
chromosome 15
chromosome 17
controlled study
disease free survival
event free survival
fatality
fusion gene
gene mutation
gene targeting
human
in vitro study
in vivo study
major clinical study
myeloid progenitor cell
overall survival
promyelocytic leukemia
reciprocal chromosome translocation
Review
risk factor
Issue Date: 2017
Citation: Ng, C.-H, Chng, W.-J (2017). Recent advances in acute promyelocytic leukaemia. F1000Research 6 : 1273. ScholarBank@NUS Repository. https://doi.org/10.12688/f1000research.10736.1
Rights: Attribution 4.0 International
Abstract: Acute promyelocytic leukaemia (APML) is a subtype of leukaemia arising from a distinct reciprocal translocation involving chromosomes 15 and 17, which results in the PML-RARA fusion gene. Over the past three decades, APML has been transformed from a highly fatal disease to a highly curable one. This drastic improvement is because of the introduction of a new treatment strategy with all-trans retinoic acid and, more recently, arsenic trioxide. The revolutionary treatment of APML has also paved the way for a new cancer treatment, which is genetically targeted therapy. In this review, we look into this amazing journey of transformation and provide recent advances in the management of APML. © 2017 Ng CH and Chng WJ.
Source Title: F1000Research
URI: https://scholarbank.nus.edu.sg/handle/10635/178716
ISSN: 20461402
DOI: 10.12688/f1000research.10736.1
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_12688_f1000research_10736_1.pdf655.71 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons